Update of the World Health Organization’s Mental Health Gap Action Programme Guideline for Psychoses (Including Schizophrenia)
Schizophrenia Bulletin · 08.11.2024 · 50 (6) · 1310-1325
DOI: 10.1093/schbul/sbae043 ↗Kurz gefasst
Leitlinie in der Zeitschrift Schizophrenia Bulletin, online erschienen am 03.05.2024. Verfasst von Carolin Lorenz und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry and Psychotherapy, School of Medicine, Technical University of Munich, Munich, Germany. Hauptthemen laut MEDLINE: World Health Organization, Psychotic Disorders, Schizophrenia, Practice Guidelines as Topic. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: World Health Organization, WHO.
Abstract (Originalsprache)
Background and Hypothesis The World Health Organization’s (WHOs) Mental Health Gap Action Programme (mhGAP) aims to improve healthcare for mental, neurological, and substance use disorders in nonspecialized settings, with a focus on low- and middle-income countries (LMICs). mhGAP includes guidelines for the treatment of psychoses (including schizophrenia), which were recently updated in 2023. The complexity of the WHO guideline update process and the updated recommendations on psychoses are presented. Study Design The WHO guideline development process is outlined as well as the evidence appraisal and the translation of the evidence into recommendations following the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) methodology. The guideline update process includes a review of the literature, a compilation of systematic reviews, and extracting data related to critical and important outcomes. The updated recommendations and the justifying evidence are discussed. Study Results The WHO mhGAP guidelines for psychoses are adapted to LMICs, and consist of 13 recommendations in 2023, whereof 5 were updated, and 1 recommendation was newly developed. Background information on how these recommendations were obtained, and significant changes since the previous guideline update in 2015 are provided. Conclusions Unlike other guidelines, the WHO must consider various countries, contextual factors, and the WHO Model Lists of Essential Medicines when developing its guidelines. A transformation of the WHO guideline for psychoses into a living guideline would ensure always up-to-date recommendations and facilitate shared decision-making.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Psychiatry and Psychotherapy, School of Medicine, Technical University of Munich, Munich, Germany.
- Department of Mental Health and Substance Use, WHO, Geneva, Switzerland.
- Division of Insurance Medicine, Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden.
ORCID-Profile: Carolin Lorenz, Stefan Leucht
Förderung
- World Health Organization
- WHO
Zitieren
APA
Lorenz, C., Bighelli, I., Hanna, F., Akhtar, A., & Leucht, S. (2024). Update of the World Health Organization’s Mental Health Gap Action Programme Guideline for Psychoses (Including Schizophrenia). Schizophrenia Bulletin, 50(6), 1310-1325. https://doi.org/10.1093/schbul/sbae043
Vancouver
Lorenz C, Bighelli I, Hanna F, Akhtar A, Leucht S. Update of the World Health Organization’s Mental Health Gap Action Programme Guideline for Psychoses (Including Schizophrenia). Schizophrenia Bulletin. 2024;50(6):1310-1325. doi:10.1093/schbul/sbae043
BibTeX
@article{Lorenz2024,
author = {Lorenz, Carolin and Bighelli, Irene and Hanna, Fahmy and Akhtar, Aemal and Leucht, Stefan},
title = {Update of the World Health Organization’s Mental Health Gap Action Programme Guideline for Psychoses (Including Schizophrenia)},
journal = {Schizophrenia Bulletin},
year = {2024},
volume = {50},
number = {6},
pages = {1310--1325},
doi = {10.1093/schbul/sbae043}
}
EUVIMED